Bemarituzumab (Anti-FGFR2 / CD332)
A2497
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameBemarituzumab (Anti-FGFR2 / CD332)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionBemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD.
- Storage Instruction-20°C
- UNSPSC12352203